Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2012

01.07.2012 | Clinical Trial

Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery

verfasst von: Ellen W. Levy, Lucinda A. Pfalzer, Jerome Danoff, Barbara A. Springer, Charles McGarvey, Ching-yi Shieh, Alicia Morehead-Gee, Lynn H. Gerber, Nicole L. Stout

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study are (1) to determine if upper extremity function, as represented by shoulder ROM, self-reported symptoms and upper extremity functional limitations in activities of daily living could be predictively related to demographic and cancer characteristics post-surgery for breast cancer. And (2) to examine if variables related to early onset impairment contribute to late onset impairments in women after breast cancer surgery. Subjects were assessed preoperatively and 1, 3, 6, 9, and 12+ months post breast cancer surgery for impairments and symptoms and at 12+ months for shoulder functional limitations using a physical therapy surveillance model. Body weight, shoulder ROM, manual muscle testing, and upper limb volume were recorded. At 12+ months, the Harvard Alumni Health Study Physical Activity Questionnaire, and an Upper Limb Disability Questionnaire were administered. Symptoms and ROM impairments were compared by functional limitations. Characteristics significantly associated with early ROM impairment (but not later impairment) were axillary lymph node dissection, removal of ≥15 nodes, mastectomy surgery and stage II breast cancer. Positive nodes, older age, and BMI ≥ 25 were significantly associated with reduced shoulder ROM at 12+ months. At 12+ months, only 10 % of the patients experienced ROM impairments while rates of self-reported symptoms in the affected upper extremity at 12+ months were as follows: pain—49 %, weakness—47.1 %, numbness—55.9 %, feeling tired—42.5 %. The majority of patients used the affected upper extremity for reaching without limitation, but ≥35 % reported limitation with household chores, carrying and lifting. Difficulty carrying and lifting could be predicted by BMI ≥ 25 and use of the dominant affected upper limb. Different factors are associated with early versus later ROM loss. Symptoms reported by breast cancer survivors are frequently associated with functional limitations in upper extremity tasks and warrant intervention. Physical therapy using a prospective surveillance model of care may reduce severity of ROM loss, symptoms and functional upper extremity limitations 1 year after breast cancer surgery.
Literatur
1.
Zurück zum Zitat Devoogdt N, Van Kampen M, Christiaens MR et al (2009) Short-and long-term recovery of upper limb function after axillary lymph node dissection. Eur J Cancer Care 20:77–86CrossRef Devoogdt N, Van Kampen M, Christiaens MR et al (2009) Short-and long-term recovery of upper limb function after axillary lymph node dissection. Eur J Cancer Care 20:77–86CrossRef
2.
Zurück zum Zitat Gosselink R, Rouffaer L, Vanhelden P et al (2003) Recovery of upper limb function after axillary dissection. J Surg Oncol 83:204–211PubMedCrossRef Gosselink R, Rouffaer L, Vanhelden P et al (2003) Recovery of upper limb function after axillary dissection. J Surg Oncol 83:204–211PubMedCrossRef
3.
Zurück zum Zitat Gomide LB, Matheus PC, Candido dos Reis FJ (2007) Morbidity after breast cancer treatment and physiotherapeutic performance. Int J Clin Pract 61:972–982PubMedCrossRef Gomide LB, Matheus PC, Candido dos Reis FJ (2007) Morbidity after breast cancer treatment and physiotherapeutic performance. Int J Clin Pract 61:972–982PubMedCrossRef
4.
Zurück zum Zitat Moskovitz AH, Anderson BO, Yeung RS (2001) Axillary web syndrome after axillary dissection. Am J Surg 181:434–439PubMedCrossRef Moskovitz AH, Anderson BO, Yeung RS (2001) Axillary web syndrome after axillary dissection. Am J Surg 181:434–439PubMedCrossRef
5.
Zurück zum Zitat Lauridsen MC, Overgaard M, Overgaard J et al (2008) Shoulder disability and late symptoms following surgery for early breast cancer. Acta Oncol 47:569–575PubMedCrossRef Lauridsen MC, Overgaard M, Overgaard J et al (2008) Shoulder disability and late symptoms following surgery for early breast cancer. Acta Oncol 47:569–575PubMedCrossRef
6.
Zurück zum Zitat Gerber L, Lampert M, Wood C et al (1992) Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Res Treat 21:139–145PubMedCrossRef Gerber L, Lampert M, Wood C et al (1992) Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Res Treat 21:139–145PubMedCrossRef
7.
Zurück zum Zitat Ernst M, Voogd A, Balder W et al (2002) Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol 79:151–155PubMedCrossRef Ernst M, Voogd A, Balder W et al (2002) Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol 79:151–155PubMedCrossRef
8.
Zurück zum Zitat Sclafani L, Baron RH (2008) Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction. Cancer J 14:216–222PubMedCrossRef Sclafani L, Baron RH (2008) Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction. Cancer J 14:216–222PubMedCrossRef
9.
Zurück zum Zitat Ashikaga T, Krag D, Land S et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102:111–118PubMedCrossRef Ashikaga T, Krag D, Land S et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102:111–118PubMedCrossRef
10.
Zurück zum Zitat Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663PubMedCrossRef Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663PubMedCrossRef
11.
Zurück zum Zitat Purushotham AD, Upponi S, Klevesath MB et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer. J Clin Oncol 23:4312–4321PubMedCrossRef Purushotham AD, Upponi S, Klevesath MB et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer. J Clin Oncol 23:4312–4321PubMedCrossRef
12.
Zurück zum Zitat Liu C, Guo Y, Shi J et al (2009) Late morbidity associated with tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review. Eur J Cancer 45:1560–1568PubMedCrossRef Liu C, Guo Y, Shi J et al (2009) Late morbidity associated with tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review. Eur J Cancer 45:1560–1568PubMedCrossRef
13.
Zurück zum Zitat Reitman JS, Geertzen JHB, Hoekstra HJ et al (2005) Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. EJSO 32:148–152CrossRef Reitman JS, Geertzen JHB, Hoekstra HJ et al (2005) Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. EJSO 32:148–152CrossRef
14.
Zurück zum Zitat Engel J, Kerr Schlesinger-Raab A et al (2003) Axillary surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat 79:47–57PubMedCrossRef Engel J, Kerr Schlesinger-Raab A et al (2003) Axillary surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat 79:47–57PubMedCrossRef
15.
Zurück zum Zitat Yang EJ, Park WB, Seo KS et al (2010) Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol 101:84–91PubMedCrossRef Yang EJ, Park WB, Seo KS et al (2010) Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol 101:84–91PubMedCrossRef
16.
Zurück zum Zitat Sagen A, Karesen R, Sandvik L et al (2009) Changes in arm morbidities and health-related quality of life after breast cancer surgery—a five-year follow-up study. Acta Oncol 48:1111–1118PubMedCrossRef Sagen A, Karesen R, Sandvik L et al (2009) Changes in arm morbidities and health-related quality of life after breast cancer surgery—a five-year follow-up study. Acta Oncol 48:1111–1118PubMedCrossRef
17.
Zurück zum Zitat Loftus LS, Laronga C (2009) Evaluating patients with chronic pain after breast cancer: the search for relief. JAMA 302:2034–2035PubMedCrossRef Loftus LS, Laronga C (2009) Evaluating patients with chronic pain after breast cancer: the search for relief. JAMA 302:2034–2035PubMedCrossRef
18.
Zurück zum Zitat Hack TF, Kwan WB, Thomas-MacLean RL et al (2010) Predictors of arm morbidity following breast cancer surgery. Psychooncology 19:1205–1212PubMedCrossRef Hack TF, Kwan WB, Thomas-MacLean RL et al (2010) Predictors of arm morbidity following breast cancer surgery. Psychooncology 19:1205–1212PubMedCrossRef
19.
Zurück zum Zitat Nesvold IL, Fossa S, Holm I et al (2010) Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol 49:347–353PubMedCrossRef Nesvold IL, Fossa S, Holm I et al (2010) Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol 49:347–353PubMedCrossRef
20.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds) SEER Cancer Statistics Review, 1975–2008, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011 Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds) SEER Cancer Statistics Review, 1975–2008, National Cancer Institute. Bethesda, MD. http://​seer.​cancer.​gov/​csr/​1975_​2008/​, based on November 2010 SEER data submission, posted to the SEER web site, 2011
21.
Zurück zum Zitat Box R, Reul-Hirche HM, Bullock-Saxton JE et al (2002) Shoulder movement after breast cancer surgery: results of a randomized controlled study of postoperative physiotherapy. Breast Cancer Res Treat 75:35–50PubMedCrossRef Box R, Reul-Hirche HM, Bullock-Saxton JE et al (2002) Shoulder movement after breast cancer surgery: results of a randomized controlled study of postoperative physiotherapy. Breast Cancer Res Treat 75:35–50PubMedCrossRef
22.
Zurück zum Zitat Lauridsen MC, Christiansen P, Hessov I (2005) The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer: a randomized study. Acta Oncol 44:449–457PubMedCrossRef Lauridsen MC, Christiansen P, Hessov I (2005) The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer: a randomized study. Acta Oncol 44:449–457PubMedCrossRef
23.
Zurück zum Zitat Beurskens C, van Uden CJ, Strobbe LJ (2007) The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer 7:166PubMedCrossRef Beurskens C, van Uden CJ, Strobbe LJ (2007) The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer 7:166PubMedCrossRef
24.
Zurück zum Zitat Springer B, Levy E, McGarvey C (2010) Pre operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer. Breast Cancer Res Treat 120:135–147PubMedCrossRef Springer B, Levy E, McGarvey C (2010) Pre operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer. Breast Cancer Res Treat 120:135–147PubMedCrossRef
25.
Zurück zum Zitat Brunelli C, Zecca E, Martini C et al (2010) Comparison of numerical and verbal pain ratings to measure pain exacerbations in patients with chronic cancer pain. Health Qual Life Outcomes 8:22CrossRef Brunelli C, Zecca E, Martini C et al (2010) Comparison of numerical and verbal pain ratings to measure pain exacerbations in patients with chronic cancer pain. Health Qual Life Outcomes 8:22CrossRef
26.
Zurück zum Zitat Kendall F, McCreary E, Provance P (1993) Muscle testing and function, 4th edn. Williams and Wilkins, Baltimore Kendall F, McCreary E, Provance P (1993) Muscle testing and function, 4th edn. Williams and Wilkins, Baltimore
27.
Zurück zum Zitat Lee IM, Paffenbarger RS Jr (2000) Associations of light, moderate, and vigorous intensity physical activity with longevity. The Harvard Alumni Health Study. Am J Epidemiol 151(3):293–299PubMedCrossRef Lee IM, Paffenbarger RS Jr (2000) Associations of light, moderate, and vigorous intensity physical activity with longevity. The Harvard Alumni Health Study. Am J Epidemiol 151(3):293–299PubMedCrossRef
28.
Zurück zum Zitat Lee IM, Paffenbarger RS Jr (1996) How much physical activity is optimal for health? Methodological considerations. Res Q Exerc Sport 67(2):206–208PubMed Lee IM, Paffenbarger RS Jr (1996) How much physical activity is optimal for health? Methodological considerations. Res Q Exerc Sport 67(2):206–208PubMed
29.
Zurück zum Zitat Ainsworth BE, Leon AS, Richardson MT et al (1993) Accuracy of the college alumnus physical activity questionnaire. J Clin Epidemiol 46(12):1403–1411PubMedCrossRef Ainsworth BE, Leon AS, Richardson MT et al (1993) Accuracy of the college alumnus physical activity questionnaire. J Clin Epidemiol 46(12):1403–1411PubMedCrossRef
30.
Zurück zum Zitat Paffenbarger RS Jr, Blair SN, Lee IM, Hyde RT (1993) Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc 25(1):60–70PubMedCrossRef Paffenbarger RS Jr, Blair SN, Lee IM, Hyde RT (1993) Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc 25(1):60–70PubMedCrossRef
31.
Zurück zum Zitat Cauley J, LaPorte R, Sandler RB, Schramm M, Kriska A (1987) Comparisons of methods to measure physical activity in postmenopausal women. Am J Clin Nutr 45:14–22PubMed Cauley J, LaPorte R, Sandler RB, Schramm M, Kriska A (1987) Comparisons of methods to measure physical activity in postmenopausal women. Am J Clin Nutr 45:14–22PubMed
32.
Zurück zum Zitat Gummesson C, Atroshi I, Ekdahl C (2003) The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord 4:11PubMedCrossRef Gummesson C, Atroshi I, Ekdahl C (2003) The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord 4:11PubMedCrossRef
33.
Zurück zum Zitat Gummesson C, Ward MM, Atroshi I (2006) The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet Disord 7:44PubMedCrossRef Gummesson C, Ward MM, Atroshi I (2006) The shortened disabilities of the arm, shoulder and hand questionnaire (QuickDASH): validity and reliability based on responses within the full-length DASH. BMC Musculoskelet Disord 7:44PubMedCrossRef
34.
Zurück zum Zitat Motion Joint (1985) Method of measuring and recording. American Academy of Orthopedic Surgery, Chicago Motion Joint (1985) Method of measuring and recording. American Academy of Orthopedic Surgery, Chicago
35.
Zurück zum Zitat Okunieff P, Augustine E, Hicks J et al (2004) Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol 22:2207–2213PubMedCrossRef Okunieff P, Augustine E, Hicks J et al (2004) Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol 22:2207–2213PubMedCrossRef
36.
Zurück zum Zitat Albert US, Koller M, Kopp I et al (2006) Early self reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study. Breast Cancer Res Treat 100:285–292PubMedCrossRef Albert US, Koller M, Kopp I et al (2006) Early self reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study. Breast Cancer Res Treat 100:285–292PubMedCrossRef
37.
Zurück zum Zitat Karki A, Simonen R, Malkia E, Selfe J (2005) Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med 37:180–188PubMed Karki A, Simonen R, Malkia E, Selfe J (2005) Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med 37:180–188PubMed
38.
Zurück zum Zitat Madsen AH, Haugaard K, Soerensen J et al (2008) Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast 17:138–147CrossRef Madsen AH, Haugaard K, Soerensen J et al (2008) Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast 17:138–147CrossRef
39.
Zurück zum Zitat Leidenius M, Leppanen E, Krogerus L et al (2003) Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 185:127–130PubMedCrossRef Leidenius M, Leppanen E, Krogerus L et al (2003) Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 185:127–130PubMedCrossRef
40.
Zurück zum Zitat Hack T, Cohen L, Katz J et al (1999) Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17:143–149PubMed Hack T, Cohen L, Katz J et al (1999) Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17:143–149PubMed
41.
Zurück zum Zitat Temple LKF, Baron R, Cody HS et al (2002) Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9:654–662PubMedCrossRef Temple LKF, Baron R, Cody HS et al (2002) Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9:654–662PubMedCrossRef
42.
Zurück zum Zitat Bosompra K, Ashikaga T, O’Brien PJ et al (2002) Swelling, numbness, pain and their relationship to arm function among breast cancer survivors: a disablement process model perspective. Breast J 8:338–348PubMedCrossRef Bosompra K, Ashikaga T, O’Brien PJ et al (2002) Swelling, numbness, pain and their relationship to arm function among breast cancer survivors: a disablement process model perspective. Breast J 8:338–348PubMedCrossRef
43.
Zurück zum Zitat Gartner R, Jensen MB, Nielsen J et al (2009) Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 302:1985–1992PubMedCrossRef Gartner R, Jensen MB, Nielsen J et al (2009) Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 302:1985–1992PubMedCrossRef
44.
Zurück zum Zitat Swisher A, Davison C, Aranda R et al (2010) Frequency and severity of self-reported upper extremity impairments, activity limitations, and participation restrictions following breast cancer treatment. Rehabil Oncol 28:3–9 Swisher A, Davison C, Aranda R et al (2010) Frequency and severity of self-reported upper extremity impairments, activity limitations, and participation restrictions following breast cancer treatment. Rehabil Oncol 28:3–9
45.
Zurück zum Zitat Kootstra JJ, Hoekstra-Weebers JE, Rietman JS et al (2010) A longitudinal comparison of arm morbidity in stage I-II breast cancer patients with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection or axillary lymph node dissection. Ann Surg Oncol 17:2384–2394PubMedCrossRef Kootstra JJ, Hoekstra-Weebers JE, Rietman JS et al (2010) A longitudinal comparison of arm morbidity in stage I-II breast cancer patients with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection or axillary lymph node dissection. Ann Surg Oncol 17:2384–2394PubMedCrossRef
46.
Zurück zum Zitat Helms G, Kuhn T, Moser L (2009) Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection—data from a prospective randomised trial. Eur J Surg Oncol 35:696–701PubMedCrossRef Helms G, Kuhn T, Moser L (2009) Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection—data from a prospective randomised trial. Eur J Surg Oncol 35:696–701PubMedCrossRef
47.
Zurück zum Zitat Shamley DR, Srinanaganathan R, Weatherall R et al (2007) Changes in shoulder muscle size and activity following treatment for breast cancer. Breast Cancer Res Treat 1:19–27CrossRef Shamley DR, Srinanaganathan R, Weatherall R et al (2007) Changes in shoulder muscle size and activity following treatment for breast cancer. Breast Cancer Res Treat 1:19–27CrossRef
48.
Zurück zum Zitat Shamley DR, Srinanaganathan R, Oskrochi R (2009) Three-dimensional scapulothoracic motion following treatment for breast cancer. Breast Cancer Res Treat 118:315–322PubMedCrossRef Shamley DR, Srinanaganathan R, Oskrochi R (2009) Three-dimensional scapulothoracic motion following treatment for breast cancer. Breast Cancer Res Treat 118:315–322PubMedCrossRef
49.
Zurück zum Zitat Crosbie J, Kilbreath SL, Dylke E (2010) Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement. Phys Ther 90:679–692PubMedCrossRef Crosbie J, Kilbreath SL, Dylke E (2010) Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement. Phys Ther 90:679–692PubMedCrossRef
51.
Zurück zum Zitat Iannotti JP, Williams GR (eds) (2006) Disorders of the shoulder: diagnosis and management. Lippincott, Williams & Wilkins, Philadelphia Iannotti JP, Williams GR (eds) (2006) Disorders of the shoulder: diagnosis and management. Lippincott, Williams & Wilkins, Philadelphia
52.
Zurück zum Zitat Smoot B, Wong J, Cooper B et al (2010) Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv 4:167–178PubMedCrossRef Smoot B, Wong J, Cooper B et al (2010) Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv 4:167–178PubMedCrossRef
53.
Zurück zum Zitat Chachaj A, Malyszczak K, Pyszel K et al (2010) Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 19(3):299–305PubMedCrossRef Chachaj A, Malyszczak K, Pyszel K et al (2010) Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 19(3):299–305PubMedCrossRef
54.
Zurück zum Zitat Stout Gergich NL, Pfalzer LA, McGarvey C (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112:2809–2819PubMedCrossRef Stout Gergich NL, Pfalzer LA, McGarvey C (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112:2809–2819PubMedCrossRef
55.
Zurück zum Zitat Hodges P (2011) Pain and motor control: from the laboratory to rehabilitation. J Electromyogr Kinesiol 21(2):220–228PubMedCrossRef Hodges P (2011) Pain and motor control: from the laboratory to rehabilitation. J Electromyogr Kinesiol 21(2):220–228PubMedCrossRef
56.
Zurück zum Zitat Devoogdt N, VanKampen M, Geraerts I (2010) Physical activity levels after treatment for breast cancer: one-year follow-up. Breast Cancer Res Treat 123:417–425PubMedCrossRef Devoogdt N, VanKampen M, Geraerts I (2010) Physical activity levels after treatment for breast cancer: one-year follow-up. Breast Cancer Res Treat 123:417–425PubMedCrossRef
57.
Zurück zum Zitat Hayes SC, Rye S, Battistutta D et al (2010) Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes 8:92PubMedCrossRef Hayes SC, Rye S, Battistutta D et al (2010) Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes 8:92PubMedCrossRef
58.
Zurück zum Zitat Lee T, Kilbreath SL, Refshauge KM et al (2008) Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 110:19–37PubMedCrossRef Lee T, Kilbreath SL, Refshauge KM et al (2008) Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 110:19–37PubMedCrossRef
59.
Zurück zum Zitat Gerber LH, Stout N, McGarvey C et al (2010) Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. doi:10.1007/s00520-010-0986-7 Gerber LH, Stout N, McGarvey C et al (2010) Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. doi:10.​1007/​s00520-010-0986-7
60.
Zurück zum Zitat Reinertsen KV, Cvancarova M, Loge JH et al (2010) Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv 4:405–414PubMedCrossRef Reinertsen KV, Cvancarova M, Loge JH et al (2010) Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv 4:405–414PubMedCrossRef
61.
Zurück zum Zitat Wielgus KK, Berger AM, Hertzog M (2009) Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncol Nurs Forum 36:38–48PubMedCrossRef Wielgus KK, Berger AM, Hertzog M (2009) Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncol Nurs Forum 36:38–48PubMedCrossRef
62.
Zurück zum Zitat Popko K, Gorska E, Stelmaszczyk-Emmel A et al (2010) Proinflammatory cytokines IL-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res 15(Suppl 2):120–122PubMed Popko K, Gorska E, Stelmaszczyk-Emmel A et al (2010) Proinflammatory cytokines IL-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res 15(Suppl 2):120–122PubMed
63.
Zurück zum Zitat Mills PJ, Parker B, Dimsdale JE et al (2005) The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 69:85–96PubMedCrossRef Mills PJ, Parker B, Dimsdale JE et al (2005) The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 69:85–96PubMedCrossRef
Metadaten
Titel
Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery
verfasst von
Ellen W. Levy
Lucinda A. Pfalzer
Jerome Danoff
Barbara A. Springer
Charles McGarvey
Ching-yi Shieh
Alicia Morehead-Gee
Lynn H. Gerber
Nicole L. Stout
Publikationsdatum
01.07.2012
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2012
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2061-1

Weitere Artikel der Ausgabe 1/2012

Breast Cancer Research and Treatment 1/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.